Investor Relations task is to continuously provide the capital market with information about ChromoGenics operation and financial development. Please contact us if you have questions or comments.
- The board of ChromoGenics advises against TopRight Nordics’ takeover bid March 10, 2021
- TopRight submits public bids for shares and warrants in ChromoGenics March 3, 2021
- ChromoGenics receives an order in excess of EUR 2.3 million from Norwegian Betonmast March 2, 2021
- Year-End Report 2020 February 19, 2021
- Interim Report January – September 2020 November 13, 2020